Metabolon is the global leader in metabolomics, the large-scale study of small molecules involved in metabolism. The company, based in Research Triangle Park, North Carolina, has been operating for over 25 years. Its work is supported by a 40,000-square-foot facility housing CLIA-certified and CAP-accredited laboratories. Research leveraging its platform has been cited in more than 4,000 peer-reviewed publications.
The company delivers biological insights for life sciences research and drug development across a range of sectors, including biopharma, population health, oncology, neuroscience, and agriculture. Its technical domains encompass metabolomics, lipidomics, bioinformatics, and microbiome solutions. Metabolon's platform is capable of identifying over 5,400 metabolites, with coverage across more than 70 major biochemical pathways.
Metabolon's products include the Global Discovery Panel, described as the industry standard for metabolomic analyses, and the Metabolon Verus™ Metabolomics Profiling Kit, which extends its capabilities to laboratories worldwide through a kit-based workflow.
